Since 1997, SIMM and Servier have established various collaborative projects in the areas of high-throughput screening, Alzheimer’s disease and diabetes. In 2007, both parties set up the joint laboratory based on prior 10-year collaboration focusing on drug development in central nervous system, oncology and diabetes. Moreover, in 2012 SIMM and Servier agreed to enter into a new agreement to establish a joint discovery and biopharmaceutical research laboratory for early stage ADME/T evaluation.